Arkolith/Insider Trading/ZVRA/Form 4

Sangiovanni Timothy J.

SVP, Finance & Corp ControllerZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Feb 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2026Option exercise(M)12K——33K
Jan 30, 2026Sell(S)2K$8.82$15K21K
Jan 30, 2026Option exercise(M)6K——23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2026Option exercise(M)12K—$012K
Jan 30, 2026Option exercise(M)6K—$013K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001698328-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML